Stem Cells and Spinal Cord Injury Repair

Advances in Experimental Medicine and Biology

Volumn 760, Issue , 2012, Pages 53-73

  Karimi Abdolrezaee, Soheila ^a   Eftekharpour, Eftekhar ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Neural Stem Cell; Pluripotent Stem Cell; Spinal Cord; Spinal Cord Injury; Stem Cell

Indexed keywords

GROWTH FACTOR;

CELL BASED GENE THERAPY; FIBROBLAST; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HUMAN EMBRYONIC STEM CELL; INDUCED PLURIPOTENT STEM CELL; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NEUROPATHOLOGY; NONHUMAN; OLFACTORY ENSHEATHING CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SCHWANN CELL; SPINAL CORD INJURY; SPINAL CORD REGENERATION; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; METHODOLOGY; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SPINAL CORD; STEM CELL;

ANIMALS; HUMANS; NERVE REGENERATION; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84872792309     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-4090-1_4     Document Type: Chapter

References (96)

1. Agrawal S, Fehlings M. Mechanisms of secondary injury to spinal cord axons in virto: role of Na+, Na+-K+-ATPase, the Na+-Wexchanger, and the Na+-Ca2+ exchanger..J Neurosci 1996; 16:545-552.
2. Nashmi R, Fehlings MG. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Rev 2001; 38: 165-191.
3. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
4. Povlishock JT, Christman CWo The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts..J Neurotrauma 1995; 12:555-564.
5. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration..J Neurotrauma 2004; 21:754-774.
6. Fitch MT, Doller C, Combs CK et al. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma..J Neurosci 1999; 19:8182-8198.
7. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 2007.
8. Eftekharpour E, Karimi-Abdolrezaee S, Fehlings MG. Current status of experimental cell replacement approaches to spinal cord injury. Neurosurg Focus 2008; 24:E19.
9. Tator CH. Acute spinal cord injury: a review of recent studies oftreatment and pathophysiology. Can Med Assoc J 1972; 107:143-145 passim.
10. Jones TB, McDaniel EE, Popovich PG. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 2005; 11:1223-1236.
11. Crowe M, Bresnahan.I, Shuman S et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Medicine 1997; 3:73-76.
12. Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7:628-643.
13. nhibition of neuriteou tgrowth on astroglial scars in vitro..J Neurosci 1990; 10:3594-3603.
14. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006; 7:617-627.
15. Karimi-Abdolrezaee S, Eftekharpour E, Fehlings MG. Temporal and spatial patterns ofKvl.1 and Kvl.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma. EurJ Neurosci 2004; 19:577-589.
16. Ondarza AB, Ye Z, Hulsebosch CE. Direct evidence of primary afferent sprouting in distant segments following spinal cord injury inthe rat: colocalizationofGAP-43 and CGRP. Exp Neuro12003; 184:373-380.
17. Baptiste DC, Fehlings MG. Update on the treatment of spinal cord injury. Prog Brain Res 2007; 161:217-233.
18. Fehlings MG, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 1995; 132:220-228.
19. Fehlings MG, Tator CH, Linden RD. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 1989; 74:241-259.
20. Barnabe-Heider F, Frisen J. Stem cells for spinal cord repair. Cell Stem Cell 2008; 3: 16-24.
21. Karimi-Abdolrezaee S, Eftekharpour E, Wang J et al. Delayed transplantation of adult neural stem cells promotes remyelination and functional recovery after spinal cord injury..J Neurosci 2006; 26( 13): 3377-3389.
22. Karimi-Abdolrezaee S, Eftekharpour E, Wang.J et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. JNeurosci 2010; 30:1657-1676.
23. Keirstead HS, NistorG, Bernal G etal. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25:4694-4705.
24. Rossi SL, Keirstead HS. Stem cells and spinal cord regeneration. Curr Opin Biotechnol2009; 20:552-562.
25. van der Kooy D, Weiss S. Why stem cells? Science 2000; 287:1439-1441.
26. Sharp.I, Frame.I, Siegenthaler M et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010; 28:152-163.
27. McDonald JW, Liu XZ, Qu Y et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999; 5:1410-1412.
28. Vadivelu S, Platik MM, Choi Let al. Multi-germ layer lineage central nervous system repair: nerve and vascular cell generation by embryonic stem cells transplanted in the injured brain. J Neurosurg 2005; 103:124-135.
29. Klimanskaya I, Chung Y, Becker S et ai. Human embryonic stem cell lines derived from single blastomeres. Nature 2006; 444:481-485.
30. Ronaghi M, Erceg S, Moreno-Manzano V et ai. Challenges of stem cell therapy for spinal cord injury: human embryonic stem cells, endogenous neural stem cells, or induced pluripotent stem cells? Stem Cells 2010; 28:93-99.
31. Smukler SR, Runciman SB, Xu S et al. Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J Cell Bioi 2006; 172:79-90.
32. Sharp J, Keirstead HS. Therapeutic applications of oligodendrocyte precursors derived from human embryonic stem cells. Curr Opin Biotechnol 2007; 18:434-440.
33. Cloutier F, Siegenthaler MM, Nistor G et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med 2006; 1:469-479.
34. Yang D, Zhang ZJ, Oldenburg M et al. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells 2008; 26:55-63.
35. Wernig MBF, Schmandt T, Rade M et al. Functional integration of embryonic stem cell-derived neurons in vivo. J Neurosci 2004; 24:5258-5268.
36. Chambers SM, Fasano CA, Papapetrou EP et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition ofSMAD signaling. Nat Biotechnol2009; 27:275-280.
37. Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004; 22:448-456.
38. Okano H. Strategies toward CNS-regeneration using induced pluripotent stem cells. Genome Inform 2009; 23:217-220.
39. Okano H. Regeneration of the central nervous system using iPS cell-technologies. Rinsho Shinkeigaku 2009; 49: 825-826.
40. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
41. Miller RH, Bai L, Lennon DP et ai. The potential of mesenchymal stem cells for neural repair. Discov Med 2010; 9:236-242.
42. Sykova E, Homola A, Mazanec R et ai. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006; 15:675-687.
43. Sykova E, Jendelova P, Urdzikova L et ai. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell Mol Neurobiol 2006; 26: 1113-1129.
44. Park WB, Kim SY, Lee SH et ai. The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats. BMC Neurosci 2010; 11: 119.
45. Tetzlaff W, Okon EB, Karimi-Abdolrezaee S et ai. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 2010.
46. Woodbury D, Reynolds K, Black I B. Adult bone marrow stromal stem cells express germ line, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 2002; 69:908-917.
47. Woodbury D, Schwarz EJ, Prockop DJ et ai. Adult rat and human bone marrow stromal cells differentiate into neurons. JNeurosci Res 2000; 61:364-370.
48. Black IB, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cells Mol Dis 2001; 27:632-636.
49. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25:2896-2902.
50. Sasaki M, Radtke C, Tan AM et ai. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci 2009; 29:14932-14941.
51. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells ofthe adult mammalian central nervous system. Science 1992; 255: 1707-171 O.
52. Weiss S, Dunne C, Hewson J et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 1996; 16:7599-7609.
53. Morshead CM, Reynolds BA, CraigCG etai. Neural stem cells in the adult mammalian forebrain: arelatively quiescent subpopulation of subependymal cells. Neuron 1994; 13: 1071-1082.
54. Alvarez-Buylla A, Temple S. Stem cells in the developing and adult nervous system. J Neurobiol 1998; 36:105-110.
55. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 2005; 23:862-871.
56. Eftekharpour E, Karimi-Abdolrezaee S, Wang Jet ai. Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of ranvier and improved axonal conduction. J Neurosci 2007; 27:3416-3428.
57. Hofstetter CP, Holmstrom NA, Lilja JA et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005; 8:346-353.
58. Parr AM, Kulbatski I, Zahir T et al. Transplanted adult spinal cord-derived neural stem/progenitor cells promote early fimctional recovery after rat spinal cord injury. Neuroscience 2008; 155:760-770.
59. Parr AM, Kulbatski I, Tator CH. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma 2007; 24:835-845.
60. Martens OJ, Seaberg RM, van der Kooy O. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur J Neurosci 2002; 16: 1 045-1 057.
61. Hoffmann CF, Thomeer RT, Marani E. Reimplantation of ventral rootlets into the cervical spinal cord after their avulsion: an anterior surgical approach. Clin Neurol Neurosurg 1993; 95 Suppl:S 112-S 118.
62. Craig CG, Tropepe V, Morshead CM et al. 1n vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 1996; 16:2649-2658.
63. Vescovi AL, Reynolds BA, Fraser DD et al. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 1993; 11:951-966.
64. Kojima A, Tator CH. 1ntrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats. J Neurotrauma 2002; 19:223-238.
65. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
66. Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B et al. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci 2002; 20:390-403.
67. Frost EE, Nielsen JA, Le TQ et al. POGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. JNeurobiol2003; 54:457-472.
68. Takahashi K, Narita M, Yokura Met al. Human induced pluripotent stem cells on autologous feeders. PLoS One 2009; 4:e8067.
69. Takahashi K, Yamanaka S. 1nduction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
70. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324:797-801.
71. Miura K, Okada Y, Aoi T et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009; 27:743-745.
72. WolDen K, MichaellP, Mohseni Petal. piggyBactransposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458:766-770.
73. Zhou H, Li W, Zhu S et al. Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. J Bioi Chern 2010; 285:29676-29680.
74. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009; 4:381-384.
75. Kusano K, Enomoto M, Hirai T et al. Transplanted neural progenitor cells expressing mutant NT3 promote myelination and partial hindlimb recovery in the chronic phase after spinal cord injury. Biochem Biophys Res Commun 2010; 393:812-817.
76. Blesch A, Lu P, Tuszynski MH. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res Bull 2002; 57:833-838.
77. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neuro12005; 191:344-360.
78. Cao Q, He Q, Wang Y et al. Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci 2010; 30:2989-3001.
79. Grill R, Murai K, Blesch A et al. Cellular delivery ofneurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci 1997; 17:5560-5572.
80. Kim HM, Hwang DH, Lee JE et al. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One 2009; 4:e4987.
81. Cao Q XX, Devries WH, Enzmann GU et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005; 25:6947-6957.
82. Kim BG, Hwang OH et al. Overexpression of Bc1-XL in human neural stem cells promotes graft survival and functional recovery following transplantation in spinal cord injury. J Neurosci Res 2009; 87:3186-3197.
83. Johansson CB, Momma S, Clarke DL et al. 1dentification of a neural stem cell in the adult mammalian central nervous system. Cell 1999; 96:25-34.
84. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
85. Shihabuddin LS, Ray.I, Gage FH. FGF-2 is sufficient to isolate progenitors found in the adult mammalian spinal cord. Experimental Neurology 1997; 148:577-586.
86. Yoo S, Wrathall JR. Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors. Dev N eurobiol2007; 67: 860-874.
87. Yamamoto S, Nagao M, Sugimori M et al. Transcription factor expression and Notch-dependent regulation of neural progenitors in the adult rat spinal cord. J Neurosci 2001; 21:9814-9823.
88. Yamamoto S, Yamamoto N, Kitamura T et al. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neuro12001; 172: 115-127.
89. Goldman SA, Sim F. Neural progenitor cells of the adult brain. Novartis Found Symp 2005; 265:66-80; discussion 82-97.
90. Keirstead HS, Blakemore WF. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Bioi 1999; 468:183-197.
91. Horky LL, Galimi F, Gage FH et al. Fate of endogenous stem/progenitor cells following spinal cord injury. J Comp Neuro12006; 498:525-538.
92. Yang H, Lu P, McKay HM et al. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J Neurosci 2006; 26:2157-2166.
93. Mothe AJ, Tator CH. Proliferation, migration, and differentiation of endogenous ependymal region stem/ progenitor cells following minimal spinal cord injury in the adult rat. Neuroscience 2005; 131: 177-187.
94. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
95. Tator C, Fehlings M. Review ofthe secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms..J Neurosurg 1991; 75:15-26.
96. Hori Y, Yamamoto S, Nagao M et al. Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J Neurosci 2006; 26: 11948-11960.